{"title":"TET2/3-mediated 5hmC erosion at metabolic‑gene enhancers drives age‑associated T cell dysfunction independent of global DNA methylation","body":"# Hypothesis\n\nAge‑related decline in T cell function stems not from random DNA methylation drift but from progressive, locus‑specific loss of 5‑hydroxymethylcytosine (5hmC) at enhancers governing metabolic reprogramming. This erosion is catalyzed by TET2 and TET3 activity, which, paradoxically, reduces 5hmC at these sites over time, leading to enhancer hypo‑hydroxymethylation, weakened transcription of glycolysis and oxidative‑phosphorylation genes, and a shift toward a senescent, low‑energy phenotype.\n\n## Rationale\n\n- TET2/3 oxidize 5mC to 5hmC at enhancers and promoters during thymic development and effector differentiation, stabilizing genes such as Zbtb7b [1].\n- In CAR‑T cells, TET2 loss limits exhaustion and boosts persistence by fostering a memory phenotype [2], indicating that TET2 activity can modulate differentiation trajectories.\n- Genome‑wide 5hmC mapping shows enrichment in gene bodies and enhancers of active T cell genes, with tissue‑specific patterns stable early in tumorigenesis [3] and a joint‑snhmC‑seq protocol enabling simultaneous 5hmC, 5mC, and transcriptome profiling [4].\n- Gene‑body 5hmC accumulates with age in multiple mouse tissues and correlates with reduced transcriptional variance [5], whereas the TET‑TDG axis influences T cell homeostasis and function [6].\n\nThese observations suggest that TET enzymes have a dual role: early in life they deposit protective 5hmC at key regulatory loci, but with advancing age their continued activity may lead to oxidative turnover that erodes 5hmC faster than it can be replenished, especially at loci with high transcriptional demand.\n\n## Mechanistic Model\n\n1. Baseline state (young T cells) – TET2/3 are recruited by lineage‑defining transcription factors (e.g., GATA3, T-bet) to enhancers of metabolic genes (Hk2, Pfkfb3, Cpt1a), generating stable 5hmC marks that maintain an open chromatin configuration and robust transcription.\n2. Aging trigger – Chronic low‑grade inflammation and elevated NAD+ consumption increase α‑ketoglutarate (αKG) depletion and succinate accumulation, altering the TET co‑factor ratio and promoting futile cycling: TET enzymes repeatedly oxidize 5mC to 5hmC and further to 5fC/5caC, which are excised by TDG, resulting in net loss of 5hmC at these enhancers.\n3. Consequence – Enhancer hypo‑hydroxymethylation reduces binding of co‑activators (e.g., p300/CBP), diminishes RNA polymerase II pause release, and lowers expression of glycolytic and oxidative genes. T cells shift toward a quiescent, low‑ATP state, exhibit reduced proliferative capacity, and show heightened expression of inhibitory receptors (PD‑1, TIM‑3).\n4. Feedback – Diminished metabolic signaling lowers intracellular αKG, further impairing TET activity and locking the locus in a low‑5hmC state.\n\n## Testable Predictions\n\n- Prediction 1: In sorted naïve and memory CD4+ T cells from young (2‑month) vs. aged (20‑month) mice, 5hmC levels at enhancers of Hk2, Pfkfb3, and Cpt1a will be significantly lower in aged cells, while global 5mC levels remain unchanged. Measured via click‑chemistry enrichment followed by qPCR or targeted bisulfite‑oxidation sequencing.\n- Prediction 2: Pharmacological elevation of αKG (e.g., cell‑permeable dimethyl‑αKG) in aged T cells will restore 5hmC at these enhancers, increase glycolytic flux (ECAR), and improve proliferation upon anti‑CD3/CD28 stimulation.\n- Prediction 3: CRISPR‑dCas9‑TET2 catalytic domain targeted to the Hk2 enhancer in aged T cells will rescue 5hmC deposition, boost Hk2 transcription, and enhance effector cytokine production (IFN‑γ, IL‑2) without altering global DNA methylation patterns.\n- Prediction 4: Vitamin C supplementation, known to enhance TET activity, will paradoxically decrease 5hmC at metabolic enhancers in aged T cells if the futile‑cycle model is correct, detectable by simultaneous 5hmC/5mC/snhmC sequencing.\n\n## Experimental Approach\n\n1. Cohort collection: Isolate CD4+ T cells from young and aged mice (n=5 per group).\n2. 5hmC profiling: Perform click‑chemistry enrichment with >30M reads, focusing on enhancer regions defined by H3K27ac ChIP‑seq.\n3. Metabolic assay: Seahorse XF analysis for glycolysis and mitochondrial respiration.\n4. Intervention: Treat aged T cells ex vivo with dimethyl‑αKG (2 mM) or vitamin C (50 µg/mL) for 24 h; repeat 5hmC and functional assays.\n5. Genetic rescue: Lentiviral delivery of dCas9‑TET2CD to specific enhancers; assess transcript levels by RT‑qPCR and cytokine secretion by ELISA.\n\n## Falsifiability\n\nIf aged T cells show no loss of 5hmC at metabolic enhancers, or if restoring 5hmC does not improve metabolic activity or cytokine output, the hypothesis would be refuted. Conversely, confirmation would support a model where TET‑driven 5hmC erosion, rather than global methylation drift, underlies age‑related T cell metabolic decline."}